Alnylam Pharmaceuticals Balance Sheet (2009-2026) | ALNY

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Assets
Current Assets
Cash & Equivalents (Quarter)	745.77M	1,093.99M	822.15M	534.08M	575.56M	1,073.23M	868.56M	672.25M	657.80M	1,033.02M	812.69M	681.88M	968.49M	1,099.92M	966.43M	1,019.65M	1,113.68M	1,490.25M	1,657.25M	1,710.78M
Short-term Investments (Quarter)	1,101.78M	1,161.32M	1,548.62M	32.00M	1,504.15M	23.05M	28.12M	25.86M	1,372.45M	1,362.84M	1,615.52M	11.26M	1,646.27M	8.32M	1,719.92M	7.20M		1,234.38M	1,251.23M	1,298.44M
Cash & Current Investments (Quarter)	1,847.55M	2,255.32M	2,370.77M	566.08M	2,079.71M	1,096.28M	896.68M	698.10M	2,030.25M	2,395.87M	2,428.20M	693.13M	2,614.76M	1,108.24M	2,686.35M	1,026.85M	1,113.68M	2,724.62M	1,657.25M	3,009.22M
Receivables - Net (Quarter)	33.93M	141.06M	198.57M	156.53M	9.07M	184.51M	237.96M	219.43M	220.63M	325.44M	327.79M	321.38M	309.48M	353.85M	405.31M	418.04M	567.11M	964.77M	777.57M	883.96M
Receivables - Other (Quarter)	500.00M
Receivables (Quarter)	533.93M	141.06M	198.57M	156.53M	9.07M	184.51M	237.96M	219.43M	220.63M	325.44M	327.79M	321.38M	309.48M	353.85M	405.31M	418.04M	567.11M	964.77M	777.57M	883.96M
Raw Materials (Quarter)	54.34M	65.16M	14.75M	20.37M	19.14M	17.72M	22.32M	22.88M	17.45M	20.12M	23.35M	25.40M	26.02M	22.36M	23.96M	23.40M	22.87M	22.25M	14.18M	11.69M
Work In Process (Quarter)	25.31M	33.12M	100.94M	91.26M	100.19M	102.45M	113.78M	110.98M	116.66M	88.69M	76.96M	76.07M	66.53M	69.86M	64.98M	53.99M	43.78M	35.50M	65.12M	65.46M
Finished Goods (Quarter)	16.45M	12.67M	7.00M	10.43M	13.19M	21.48M	25.61M	29.53M	28.50M	27.66M	25.12M	24.82M	27.86M	23.13M	26.43M	32.96M	33.75M	38.85M	32.34M	38.98M
Inventory (Quarter)	84.36M	97.90M	86.36M	78.52M	88.98M	115.49M	128.96M	131.88M	100.45M	95.77M	89.15M	93.99M	83.98M	75.99M	78.51M	65.58M	71.69M	75.38M	82.72M	84.03M
Current Deferred Tax Assets (Quarter)
Prepaid Assets (Quarter)	94.14M	108.53M	88.08M	115.06M	129.78M	125.52M	132.92M	119.03M	145.45M	157.96M	126.38M	201.96M	154.75M	145.35M	116.96M	152.42M	147.31M	188.04M	281.89M	242.10M
Current Assets (Quarter)	2,725.16M	2,675.36M	2,808.58M	2,589.68M	2,471.64M	2,690.85M	2,692.25M	2,541.02M	2,524.05M	2,985.45M	2,982.70M	2,988.61M	3,172.86M	3,355.42M	3,295.28M	3,268.26M	3,643.70M	3,952.81M	4,050.66M	4,219.31M
Non-Current Assets
Construction in Progress (Quarter)
Land & Improvements (Quarter)
Property, Plant & Equipment (Net) (Quarter)	470.70M	484.94M	501.96M	504.39M	508.20M	514.82M	523.49M	523.03M	527.47M	525.59M	526.06M	523.46M	517.16M	507.00M	502.78M	498.68M	499.79M	501.75M	513.15M	518.26M
Long-Term Investments (Quarter)	40.89M	40.89M	40.89M	40.89M	49.39M	49.39M	49.39M	49.39M	49.39M	49.39M	49.39M	49.39M	49.39M	68.59M	68.59M	68.59M	68.59M	51.31M	22.17M	22.17M
Intangibles (Quarter)
Goodwill & Intangibles (Quarter)
Long-Term Deferred Tax (Quarter)											10.10M				116.86M	107.22M	104.36M	98.56M	125.97M	116.96M
Other Non-Current Assets (Quarter)	34.59M	35.27M	60.20M	69.82M	77.27M	61.40M	66.09M	63.45M	92.69M	75.16M	61.90M	67.46M	71.92M	77.62M	65.31M	73.82M	57.17M	55.84M	59.46M	63.55M
Non-Current Assets (Quarter)	784.27M	796.95M	834.73M	843.87M	858.78M	844.41M	854.11M	850.92M	878.35M	853.62M	847.18M	835.78M	836.78M	849.62M	944.70M	945.55M	922.32M	898.85M	915.67M	910.24M
Assets (Quarter)	3,509.43M	3,472.31M	3,643.30M	3,433.55M	3,330.42M	3,535.26M	3,546.36M	3,391.94M	3,402.40M	3,839.07M	3,829.88M	3,824.39M	4,009.63M	4,205.04M	4,239.98M	4,213.81M	4,566.02M	4,851.66M	4,966.33M	5,129.55M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	53.08M	40.05M	73.43M	54.92M	52.42M	40.57M	98.09M	62.24M	59.75M	73.84M	55.52M	78.15M	73.98M	70.81M	88.42M	97.40M	102.39M	117.59M	115.72M	126.63M
Payables (Quarter)	53.08M	40.05M	73.43M	54.92M	52.42M	40.57M	98.09M	62.24M	59.75M	73.84M	55.52M	78.15M	73.98M	70.81M	88.42M	97.40M	102.39M	117.59M	115.72M	126.63M
Accumulated Expenses (Quarter)	341.19M	388.58M	395.17M	355.94M	421.24M	510.58M	545.46M	508.60M	598.53M	713.09M	713.01M	698.87M	808.64M	946.17M	793.69M	704.16M	918.97M	1,153.65M	1,080.20M	946.49M
Other Accumulated Expenses (Quarter)
Short term Debt (Quarter)															93.78M	118.10M	120.79M	121.30M
Current Leases (Quarter)	39.36M	40.61M	40.55M	41.29M	41.24M	41.58M	41.97M	43.05M	42.07M	41.52M	41.51M	41.67M	41.66M	42.14M	41.89M	46.01M	46.10M	44.76M	45.52M	45.66M
Current Taxes (Quarter)
Current Deferred Revenue (Quarter)	82.26M	76.45M	149.48M	131.84M	114.29M	144.21M	42.10M	35.79M	54.64M	77.14M	102.75M	76.85M	69.01M	71.03M	55.48M	28.16M	15.08M	2.54M	4.84M	3.21M
Curent Deferred Tax Liability (Quarter)
Total Current Liabilities (Quarter)	554.65M	610.66M	695.71M	605.96M	657.68M	772.79M	767.91M	673.39M	788.64M	949.78M	967.79M	941.71M	1,055.25M	1,220.66M	1,186.27M	1,075.62M	1,300.85M	1,555.48M	1,466.35M	1,349.47M
Non-Current Liabilities
Non-Current Debt (Quarter)			675.70M
Convertible Debt (Quarter)						1,015.98M	1,016.94M	1,017.89M	1,018.84M	1,019.81M	1,020.78M	1,021.73M	1,022.69M	1,023.65M	1,024.62M	1,025.57M	1,026.52M	1,040.28M	1,007.78M	1,009.37M
Non-Current Deffered Revenue (Quarter)	202.39M	177.12M	152.36M	157.67M	175.34M	132.93M	193.79M	191.26M	194.13M	196.09M	188.18M	185.51M	2.40M	1.01M
Operating Leases (Quarter)	288.56M	286.03M	281.35M	277.39M	272.02M	266.32M	261.34M	259.40M	253.42M	247.71M	243.10M	237.83M	239.35M	236.03M	229.54M	230.06M	224.44M	223.42M	225.09M	218.03M
Other Non-Current Liabilities (Quarter)	71.63M	76.45M	98.96M	120.83M	157.30M	183.00M	212.58M	224.05M	257.05M	280.73M	308.44M	319.99M	350.43M	357.48M	393.10M	5.87M	407.50M	9.77M	7.59M	7.61M
Total Non-Current Liabilities (Quarter)	2,584.43M	2,639.97M	2,956.14M	2,911.55M	2,997.08M	3,419.89M	3,492.00M	3,427.13M	3,553.47M	3,724.20M	3,742.09M	3,723.67M	3,662.27M	3,815.21M	3,779.80M	4,092.51M	3,907.93M	4,608.00M	4,169.56M	4,046.56M
Total Liabilities (Quarter)	2,656.07M	2,716.42M	3,055.10M	3,032.38M	3,154.38M	3,602.89M	3,704.58M	3,651.18M	3,810.53M	4,004.94M	4,050.52M	4,043.66M	4,012.70M	4,172.69M	4,172.90M	4,098.38M	4,315.43M	4,617.77M	4,177.15M	4,054.17M
Shareholder's Equity
Total Debt (Quarter)			675.70M												93.78M	118.10M	120.79M	121.30M
Common Equity (Quarter)	853.36M	755.89M	588.20M	401.17M	176.04M	-67.64M	-158.22M	-259.24M	-408.13M	-165.87M	-220.64M	-219.27M	-3.07M	32.35M	67.09M	115.44M	250.59M	233.89M	789.18M	1,075.38M
Shareholder's Equity (Quarter)	853.36M	755.89M	588.20M	401.17M	176.04M	-67.64M	-158.22M	-259.24M	-408.13M	-165.87M	-220.64M	-219.27M	-3.07M	32.35M	67.09M	115.44M	250.59M	233.89M	789.18M	1,075.38M
Liabilities and Shareholders Equity (Quarter)	3,509.43M	3,472.31M	3,643.30M	3,433.55M	3,330.42M	3,535.26M	3,546.36M	3,391.94M	3,402.40M	3,839.07M	3,829.88M	3,824.39M	4,009.63M	4,205.04M	4,239.98M	4,213.81M	4,566.02M	4,851.66M	4,966.33M	5,129.55M
Retained Earnings (Quarter)	-4975.22M	-34.23M	-33.26M	-38.06M	-42.22M	-6361.86M	-44.65M	-39.12M	-7019.47M	-6871.72M	-23.38M	-7075.53M	-7092.41M	-7203.98M	-7287.75M	-37.52M	-7411.50M	-21.77M	-20.10M	-6496.53M
Treasury Shares (Quarter)			1.14M				0.29M				1.03M				1.73M				0.78M

Research Tools

Alnylam Pharmaceuticals Balance Sheet (2009-2026) | ALNY

Create an account

Sign In

Reset Password